Beranda › Neuroblastoma › Oregon
Uji klinis Neuroblastoma di Oregon
6 studi untuk Neuroblastoma mencari peserta di lokasi di Oregon.
Kota di Oregon
Teks studi resmi (Bahasa Inggris)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Menerima pesertaFase 3
Hingga usia 30 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Oregon Health and Science University ( Site 1004), Portland
Menerima pesertaFase 1/2
6 Months – 25 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Randall Children's Hospital, Portland
Menerima pesertaFase 2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT02559778Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Randall Children's Hospital, Portland
Menerima pesertaFase 2
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Legacy Emanuel Children's Hospital, Portland
Menerima pesertaFase 3
365 Days – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Randall Children's Hospital, Portland
Menerima pesertaFase 2
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05489887Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.